These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6418248

  • 1. Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.
    Ashkenazi R, Finberg JP, Youdim MB.
    Br J Pharmacol; 1983 Jul; 79(3):765-70. PubMed ID: 6418248
    [Abstract] [Full Text] [Related]

  • 2. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ, Marsden CA, Martin KF, Palfreyman MG.
    Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
    [Abstract] [Full Text] [Related]

  • 3. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR, Youdim MB.
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T, Satoh S, Satoh N, Kisara K, Arai Y, Kim SK, Kinemuchi H.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [Abstract] [Full Text] [Related]

  • 5. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
    Worms P, Kan JP, Wermuth CG, Roncucci R, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):241-50. PubMed ID: 3100770
    [Abstract] [Full Text] [Related]

  • 6. The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
    Sagi Y, Driguès N, Youdim MB.
    Br J Pharmacol; 2005 Oct; 146(4):553-60. PubMed ID: 16086033
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A, Nyman L, Haapalinna A, Sirviö J.
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [Abstract] [Full Text] [Related]

  • 14. The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
    Rényi L.
    Br J Pharmacol; 1986 Aug; 88(4):827-35. PubMed ID: 3091132
    [Abstract] [Full Text] [Related]

  • 15. Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T, Iwamoto N, Kitaichi Y, Kato A, Inoue T, Koyama T.
    Eur J Pharmacol; 2006 Feb 27; 532(3):258-64. PubMed ID: 16488409
    [Abstract] [Full Text] [Related]

  • 16. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
    Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA.
    Psychopharmacology (Berl); 2008 Nov 27; 201(1):55-66. PubMed ID: 18604652
    [Abstract] [Full Text] [Related]

  • 17. The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats.
    Ortmann R, Waldmeier PC, Radeke E, Felner A, Delini-Stula A.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar 27; 311(2):185-92. PubMed ID: 6966764
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of [3H]5-hydroxytryptamine binding sites in chick embryo brain by monoamine oxidase inhibitors or fenfluramine and potentiation by d,l-5-hydroxytryptophan.
    Soblosky JS, DuMontier G, Jeng I.
    J Neurochem; 1985 Dec 27; 45(6):1923-31. PubMed ID: 3932597
    [Abstract] [Full Text] [Related]

  • 19. Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
    Marley E, Wozniak KM.
    J Psychiatr Res; 1984 Dec 27; 18(2):173-89. PubMed ID: 6747915
    [Abstract] [Full Text] [Related]

  • 20. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF, Green AR.
    Br J Pharmacol; 1978 Oct 27; 64(2):201-9. PubMed ID: 708990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.